谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 23 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Complementary and Alternative Medicine Use and Glomerular Disease: A Contemporary Case Series
Prem Kumar Devaraju, Jayalakshmi Seshadri, Chelvamalai Muthukumaran Balasubramanian,Anila Abraham Kurien,Guhan Senthilkumaran, Vaishanavi Devi Rajarathinam, Vijayakumar Stanlybai Jibia, Vinoj Murugesan,Tanuj Moses Lamech,Dineshkumar Thanigachalam,Sakthirajan Ramanathan, Sheik Sulthan Alavudeen,Shivakumar Dakshinamoorthy, Seenivasan Mookaiah,Natarajan Gopalakrishnan
KIDNEY MEDICINEno. 6 (2024)
引用0浏览0WOS引用
0
0
Outcomes of Covid-19 Vaccine-Associated Glomerular Diseases (CVAGD) – A Case Series from India
Vaishanavi Devi Rajarathinam, Jayalakshmi Seshadri,Guhan Senthilkumaran, VS Jibia, Vinoj Murugesan, Prem Kumar Devaraju, Chelvamalai Muthukumaran Balasubramanian, Dinesh Kumar,Tanuj Moses Lamech,Natarajan Gopalakrishnan
Indian Journal of Nephrology（2024）
引用0浏览0引用
0
0
SARS-CoV-2 Antibody Seroprevalence and Humoral Response to Vaccination in Patients Undergoing Maintenance Hemodialysis: A Prospective Cohort Study
Guhan Senthilkumaran, Vaishanavi D. Rajarathinam, Srinivasaraman Govindarajan, V. S. Jibia, Chelvamalai M. Balasubramanian, Prem K. Devaraju, Vinoj Murugesan, P. Shankar,Tanuj M. Lamech,Venkatesh Arumugam,Natarajan Gopalakrishnan
INDIAN JOURNAL OF NEPHROLOGY（2024）
引用0浏览0WOS引用
0
0
Immunogenicity of COVID-19 Vaccination in Kidney Transplant Recipients
V S Jibia, Chelvamalai Muthukumaran,Shivakumar Dakshinamoorthy, Vaishanavi Devi Rajarathinam,Guhan Senthilkumaran, Premkumar Devaraju, Vinoj Murugesan,Venkatesh Arumugam,Tanuj Moses Lamech,Sakthirajan Ramanathan, Srinivasaraman Govindarajan,Natarajan Gopalakrishnan
Indian Journal of Transplantationno. 4 (2023): 414-417
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 24

#Citation: 92

H-Index: 4

G-Index: 6

Sociability: 5

Diversity: 2

Activity: 5

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn